Duran Mansur, Simon Florian, Ertas Neslihan, Schelzig Hubert, Floros Nikolaos
Department of Vascular and Endovascular Surgery, Heinrich-Heine University Medical Center, Düsseldorf, Germany.
Klinik für Gefäß- und Endovaskularchirurgie, Universitätsklinikum der Heinrich-Heine Universität, Moorenstr. 5, 40225, Düsseldorf, Germany.
BMC Surg. 2017 Aug 29;17(1):95. doi: 10.1186/s12893-017-0289-8.
Median arcuate ligament syndrome is a rare condition with abdominal symptoms. Accepted treatment options are open release of median arcuate ligament, laparoscopic release of edian arcuate ligament, robot-assisted release of median arcuate ligament and open vascular treatment. Here we aimed to evaluate the central priority of open vascular therapy in the treatment of median arcuate ligament syndrome.
We conducted a monocentric retrospective study between January 1996 and June 2016. Thirty-one patients with median arcuate ligament syndrome underwent open vascular surgery, including division of median arcuate ligament in 17 cases, and vascular reconstruction of the celiac artery in 14 cases.
In a 20-year period, 31 patients (n = 26 women, n = 5 men) were treated with division of median arcuate ligament (n = 17) or vascular reconstruction in combination with division of median arcuate ligament (n = 14). The mean age of patients was 44.8 ± 15.13 years. The complication rate was 16.1% (n = 5). Revisions were performed in 4 cases. The 30-day mortality rate was 0%. The mean in-hospital stay was 10.7 days. Follow-up data were obtained for 30 patients. The mean follow-up period was 52.2 months (range 2-149 months). Patients were grouped into a decompression group (n = 17) and revascularisation group (n = 13). The estimated Freedom From Symptoms rates were 93.3, 77.8, and 69.1% for the decompression group and 100, 83.3, and 83.3% for the revascularisation group after 12, 24 and 60 months respectively. We found no significant difference in the Freedom From Re-Intervention CA rates of the decompression (100% at 12, 24 and 60 months post-surgery) and revascularisation (100% at 12 months, and 91.7% at 24 and 60 months post-surgery) groups during follow-up (p = 0.26).
Open vascular treatment of median arcuate ligament syndrome is a safe, low mortality-risk procedure, with low morbidity rate. Treatment choice depends on the clinical and morphological situation of each patient.
正中弓状韧带综合征是一种伴有腹部症状的罕见病症。公认的治疗方案包括正中弓状韧带开放松解术、腹腔镜下正中弓状韧带松解术、机器人辅助正中弓状韧带松解术以及开放血管治疗。在此,我们旨在评估开放血管治疗在正中弓状韧带综合征治疗中的核心优势。
我们在1996年1月至2016年6月期间进行了一项单中心回顾性研究。31例正中弓状韧带综合征患者接受了开放血管手术,其中17例行正中弓状韧带切断术,14例行腹腔干血管重建术。
在20年的时间里,31例患者(26例女性,5例男性)接受了正中弓状韧带切断术(17例)或血管重建联合正中弓状韧带切断术(14例)。患者的平均年龄为44.8±15.13岁。并发症发生率为16.1%(5例)。4例患者进行了翻修手术。30天死亡率为0%。平均住院时间为10.7天。获得了30例患者的随访数据。平均随访时间为52.2个月(范围2 - 149个月)。患者被分为减压组(17例)和血运重建组(13例)。减压组在术后12、24和60个月时无症状率估计分别为93.3%、77.8%和69.1%,血运重建组分别为100%、83.3%和83.3%。我们发现在随访期间,减压组(术后12、24和60个月时再次干预腹腔干率均为100%)和血运重建组(术后12个月时为100%,术后24和60个月时为91.7%)再次干预腹腔干率无显著差异(p = 0.26)。
正中弓状韧带综合征的开放血管治疗是一种安全、低死亡风险且发病率低的手术。治疗选择取决于每位患者的临床和形态学情况。